2024/11/01

New version of the guidebook for TCR/BCR repertoire analysis is now available (Ver.8)

2024/10/23

Our TCR Repertoire Analysis was used in a study on novel vaccines against novel coronaviruses using pullulan nanogels (PNG), an immune system-directed, nanoparticulate drug delivery system unique to Japan

2024/09/12

Our TCR Repertoire Analysis was used in a study of confirming therapeutic efficacy of IL-7 and CCL19-producing CAR-T cells against glioblastoma and pancreatic cancer with mouse model

2024/08/15

A paper on the evaluation of the immune response of Omicron XBB.1.5 mRNA vaccine using BCR Repertoire Analysis has been published

2024/07/22

Our Bacterial Flora Analysis was used to study the relationship between inflammation and microflora in intratarsal keratinous cysts

2024/07/22

Our TCR Repertoire Analysis was used in a study of the association between activated regulatory T cells and cancer immunosuppression in head and neck squamous cell carcinoma cancer tissues

2024/07/03

Research utilizing our technology has been adopted by the Japan Agency for Medical Research and Development (AMED) under its Translational Research Program

2024/07/01

Our TCR Repertoire Analysis was used in a study of Human iPSC-derived CD4+ Treg-like cells

2024/05/29

Our Bacterial Flora Analysis was used in a study for the protective effect of chronic intake soy peptide supplementation on behavioral disorders caused by juvenile social isolation

2024/05/07

Our Bacterial Flora Analysis was used in a study for the relationship between induction of cancer cachexia and intestinal microbiota